home / stock / medp / medp articles


MEDP Articles, Medpace Holdings Inc.

Stock Information

Company Name: Medpace Holdings Inc.
Stock Symbol: MEDP
Market: NASDAQ
Website: medpace.com

Menu

MEDP MEDP Quote MEDP Short MEDP News MEDP Articles MEDP Message Board
Get MEDP Alerts

News, Short Squeeze, Breakout and More Instantly...

Here's Why Holding Align Technology Stock Could Pay Off | Benzinga

Align Technology, Inc's (NASDAQ: ALGN) successful efforts to broaden the Invisalign portfolio are poised to bring significant growth in th...

Here's Why Staying Invested in Neogen Could be Beneficial | Benzinga

Neogen Corporation (NASDAQ: NEOG) effectively progresses with its strategic growth pillars, placing the company well for future success. The A...

Quest Diagnostics to Expand in Canada With LifeLabs Buyout | Benzinga

Quest Diagnostics (NYSE: DGX) has entered into a definitive agreement with OMERS to acquire LifeLabs, a prominent Canadian provider of community la...

Breaking Update: Dani S Zander Engages In Options Exercise At Medpace Hldgs | Benzinga

Highlighted on July 3, it was unveiled in an SEC filing that Zander, Director at Medpace Hldgs (NASDAQ:MEDP), executed a significant transaction in...

Neuronetics Expands NeuroStar Portfolio With New Launch | Benzinga

Neuronetics, Inc. (NASDAQ: STIM) recently announced the nationwide launch of the Better Me Provider (BMP) program. The BMP program will be a part o...

Is It the Right Time to Hold Labcorp in Your Portfolio? | Benzinga

Laboratory Corporation of America Holdings (NYSE: LH), or Labcorp's, focused efforts in the high-growth areas position it for strong growth in ...

QIAGEN Backs New AAP Guidelines Supporting QFT-Plus Test | Benzinga

QIAGEN N.V. (NYSE: QGEN) recently lauded the new guidelines in the United States that recommend screening at-risk children of all ages for lat...

Charles River's RMS Growth Aids Amid FX Headwind | Benzinga

Charles River Laboratories' (NYSE: CRL) Research Models and Services (RMS) business continues to benefit from the Charles River Accelerator and...

Illumina Rises on Conclusion of GRAIL Divestment | Benzinga

Following three years of nonstop regulatory hassles, Illumina (NASDAQ: ILMN) finally gave up on GRAIL (NASDAQ: GRAL), leading to the successful com...

Abbott's EPD Expansion Continues Despite FX Headwind | Benzinga

Abbott's (NYSE: ABT) diversified business portfolio is well-positioned to drive continued momentum in 2024. However, a challenging macroeconomi...

Next 10